Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysis

Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer

(2022) Hongcheng Lu et al.   Frontiers in Immunology

Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer

(2022) Cheng-Shuo Huang et al.   Cancers

Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day

(2022) Brigida Anna Maiorano et al.   Biomedicines

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1

(2021) Zaoqu Liu et al.   Frontiers in Oncology

Targeting SLC1A5 blocks cell proliferation through inhibition of mTORC1 in arsenite-treated human uroepithelial cells

(2021) Sihao Li et al.   TOXICOLOGY LETTERS

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer

(2021) Yilin Yan et al.   Frontiers in Cell and Developmental Biology

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer

(2021) Fei Xu et al.   Frontiers in Genetics

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer

(2021) Zaoqu Liu et al.   EBioMedicine

Tumor Heterogeneity and Consequences for Bladder Cancer Treatment

(2021) Etienne Lavallee et al.   Cancers

Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy

(2019) Chrétien et al.   Cancers

Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma

(2019) Gottfrid Sjödahl et al.   INTERNATIONAL JOURNAL OF CANCER

Screening and identification of key biomarkers in bladder carcinoma: Evidence from bioinformatics analysis

(2018) Meiqin Yan et al.   Oncology Letters

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

(2018) Sanjeev Mariathasan et al.   NATURE

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

(2018) Jun Wang et al.   CELL

A novel messenger RNA and long noncoding RNA signature associated with the progression of nonmuscle invasive bladder cancer

(2018) Yu-hui He et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

Urothelial Carcinoma of the Bladder and the Rise of Immunotherapy

(2017) David D. Chism   Journal of the National Comprehensive Cancer Network

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

(2017) Pornpimol Charoentong et al.   Cell Reports

CTLA-4 and PD-1 Pathways

(2016) Elizabeth I. Buchbinder et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes

(2016) Jakub Dobruch et al.   EUROPEAN UROLOGY

The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses

(2016) Lindsay K. Ward-Kavanagh et al.   IMMUNITY

Advances in Cancer Immunotherapy in Solid Tumors

(2016) Smitha Menon et al.   Cancers

Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients

(2015) William Martin-Doyle et al.   JOURNAL OF CLINICAL ONCOLOGY

Combination cancer immunotherapy and new immunomodulatory targets

(2015) Kathleen M. Mahoney et al.   NATURE REVIEWS DRUG DISCOVERY

HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families

(2015) Murali Janakiram et al.   OncoImmunology

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

(2013) Gabriela Bindea et al.   IMMUNITY

BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer

(2010) A. Font et al.   ANNALS OF ONCOLOGY